Michigan Flu VE (MFIVE) Study

Young girl blowing her nose wrapped in a blanket sitting on a couch

Helping Improve Our Understanding of Respiratory Viruses and Vaccine Effectiveness

The University of Michigan-Henry Ford Influenza Vaccine Effectiveness Study (MFIVE) is a public health surveillance program. In collaboration with the University of Michigan, Henry Ford Health is one of several institutions across the United States that contribute to the U.S. Flu Vaccine Effectiveness Network sponsored by the Centers for Disease Control and Prevention (CDC). Together, this initiative monitors the effectiveness of vaccines used to prevent respiratory illness in real-world conditions. The important data we collect helps the CDC make real-time policy decisions and vaccine recommendations.

Why This Research Matters

A man receiving a flu shot in his arm from a nurse

Respiratory viruses such as influenza (Flu), Respiratory Syncytial Virus (RSV) and SARS-CoV-2 (COVID-19) continue to impact individuals, families, and communities each year. By studying how these viruses spread and how vaccines perform in real-world settings, researchers can generate important evidence that helps guide public health strategies and vaccine recommendations.

The study uses a test-negative design, which compares flu vaccination rates among people with confirmed flu illness versus people with similar illness who do not have flu based on laboratory tests. More information on the study methods used by the US Flu VE Network is available at How Flu Vaccine Effectiveness and Efficacy Are Measured.

The MFIVE Study supports research that may:

  • Improve understanding of respiratory virus patterns and trends
  • Evaluate how well vaccines work during each season
  • Identify factors that may increase the risk of illness
  • Support future public health planning and prevention efforts
  • Strengthen representation of diverse communities in research

US Flu VE Network Study Sites

The network consists of seven primary study sites and one coordinating center (Duke University) spread across the United States:

Uniter States map showing Flu VE network

Overseeing the study locally from our Henry Ford Health team:

Head shot of Ivana Vaughn, PhD 
Site Principal Investigator
Assistant Scientist
Head shot of Maria the study manager 
Maria Santana-Garcés, MPH
Study Manager
Epidemiologist II
  • Who is eligible to participate?
    • Age 8 months or older (adults or children)
    • Recently developed respiratory symptoms
    • Have a cough
    • Symptoms began within the last 7 days
    • Seeking healthcare for current respiratory illness
  • What is the purpose of this study?

    The MFIVE study helps researchers understand:

    • How well vaccines work
    • How respiratory viruses spread
    • How illness affects patients and families
    • How public health responses can be improved
  • What happens during my visit?

    Meet the study team

    • We’ll explain the study and answer your questions

    Complete a survey

    • Questions may ask about: symptoms, vaccination history, and general health information

    Provide a sample

    • A nasal and throat swab may be collected

    Receive your thank-you incentive

    • Eligible participants may receive compensation for participation.[
  • Study timeline

    At enrollment:

    • Complete a baseline survey that asks about symptoms, vaccination history, basic demographic information, etc.
      taff collect a respiratory sample consisting of a nasal and throat swab

    7-14 days after enrollment

    • Participants complete the follow-up survey online or over the phone
  • Is Participant information protected?
    • Researchers follow strict privacy and confidentiality requirements as outlined by the Health Insurance Portability and Accountability Act (HIPPA).
    • Personally identifiable information is not shared with[VI8.1] the CDC, but is collected internally for the purposes of providing compensation.
    • Participation is voluntary, participants may withdraw from the study at any time.
  • Why are samples collected?

    Samples help researchers:

    • Identify respiratory viruses
    • Evaluate vaccine effectiveness
    • Improve prevention strategies
    • Support future outbreak preparedness
  • Who conducts this study?

    MFIVE is a collaboration among:

    • University of Michigan
    • Henry Ford Health
    • Duke Clinical Research Institute
    • Center for Disease Control and Prevention (CDC) / U.S. Influenza Vaccine Effectiveness Network
  • Will participants have access to test results?
    • No, the nasal and throat swab collected for the purposes of this study is separate from any testing patients may receive during their clinical appointment.
    • If a participant received a clinical test as part of their standard clinical appointment, they can access their results through MyChart.

Questions?

Contact the MFIVE study team at Henry Ford Health:

Phone: (313) 874-3014
Email: MFIVEstudy@hfhs.org

Cookie Consent

We use cookies to improve your website experience. By using this site, you agree to our Terms of Use. Read our Internet Privacy Statement  to learn what information we collect and how we use it.

Accept All
Dismiss